These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 9251232)

  • 1. Gas chromatographic/mass spectrometric determination of lysergic acid diethylamide (LSD) in serum samples.
    Musshoff F; Daldrup T
    Forensic Sci Int; 1997 Aug; 88(2):133-40. PubMed ID: 9251232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of LSD in blood by capillary electrophoresis with laser-induced fluorescence detection.
    Frost M; Köhler H; Blaschke G
    J Chromatogr B Biomed Sci Appl; 1997 Jun; 693(2):313-9. PubMed ID: 9210434
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Automated extraction of lysergic acid diethylamide (LSD) and N-demethyl-LSD from blood, serum, plasma, and urine samples using the Zymark RapidTrace with LC/MS/MS confirmation.
    de Kanel J; Vickery WE; Waldner B; Monahan RM; Diamond FX
    J Forensic Sci; 1998 May; 43(3):622-5. PubMed ID: 9608700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gas chromatographic-electron-impact mass fragmentometric determination of lysergic acid diethylamide in urine.
    Paul BD; Mitchell JM; Burbage R; Moy M; Sroka R
    J Chromatogr; 1990 Jul; 529(1):103-12. PubMed ID: 2211923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of an ultra-fast and sensitive microflow liquid chromatography-tandem mass spectrometry (MFLC-MS/MS) method for quantification of LSD and its metabolites in plasma and application to a controlled LSD administration study in humans.
    Steuer AE; Poetzsch M; Stock L; Eisenbeiss L; Schmid Y; Liechti ME; Kraemer T
    Drug Test Anal; 2017 May; 9(5):788-797. PubMed ID: 27422082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of EMIT II, CEDIA, and DPC RIA assays for the detection of lysergic acid diethylamide in forensic urine samples.
    Wiegand RF; Klette KL; Stout PR; Gehlhausen JM
    J Anal Toxicol; 2002 Oct; 26(7):519-23. PubMed ID: 12423010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A selective and sensitive method for quantitation of lysergic acid diethylamide (LSD) in whole blood by gas chromatography-ion trap tandem mass spectrometry.
    Libong D; Bouchonnet S; Ricordel I
    J Anal Toxicol; 2003; 27(1):24-9. PubMed ID: 12587679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of lysergic acid diethylamide: comparison of capillary electrophoresis with laser-induced fluorescence (CE-LIF) with conventional techniques.
    Frost M; Köhler H
    Forensic Sci Int; 1998 Apr; 92(2-3):213-8. PubMed ID: 9627980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and Concentration-Effect Relationship of Oral LSD in Humans.
    Dolder PC; Schmid Y; Haschke M; Rentsch KM; Liechti ME
    Int J Neuropsychopharmacol; 2015 Jun; 19(1):. PubMed ID: 26108222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effective GC-MS procedure for detecting iso-LSD in urine after base-catalyzed conversion to LSD.
    Clarkson ED; Lesser D; Paul BD
    Clin Chem; 1998 Feb; 44(2):287-92. PubMed ID: 9474026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of lysergic acid diethylamide (LSD) in urine by gas chromatography-ion trap tandem mass spectrometry.
    Sklerov JH; Kalasinsky KS; Ehorn CA
    J Anal Toxicol; 1999 Oct; 23(6):474-8. PubMed ID: 10517553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative determination of LSD and a major metabolite, 2-oxo-3-hydroxy-LSD, in human urine by solid-phase extraction and gas chromatography-tandem mass spectrometry.
    Reuschel SA; Percey SE; Liu S; Eades DM; Foltz RL
    J Anal Toxicol; 1999 Sep; 23(5):306-12. PubMed ID: 10488916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of an LC-MS/MS method to quantify lysergic acid diethylamide (LSD), iso-LSD, 2-oxo-3-hydroxy-LSD, and nor-LSD and identify novel metabolites in plasma samples in a controlled clinical trial.
    Dolder PC; Liechti ME; Rentsch KM
    J Clin Lab Anal; 2018 Feb; 32(2):. PubMed ID: 28548305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of buprenorphine, fentanyl and LSD in whole blood by UPLC-MS-MS.
    Berg T; Jørgenrud B; Strand DH
    J Anal Toxicol; 2013 Apr; 37(3):159-65. PubMed ID: 23423312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validation of an LC-MS/MS method for the quantitative analysis of 1P-LSD and its tentative metabolite LSD in fortified urine and serum samples including stability tests for 1P-LSD under different storage conditions.
    Grumann C; Henkel K; Stratford A; Hermanns-Clausen M; Passie T; Brandt SD; Auwärter V
    J Pharm Biomed Anal; 2019 Sep; 174():270-276. PubMed ID: 31181490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid chromatography-electrospray ionization mass spectrometry for the detection of lysergide and a major metabolite, 2-oxo-3-hydroxy-LSD, in urine and blood.
    Sklerov JH; Magluilo J; Shannon KK; Smith ML
    J Anal Toxicol; 2000 Oct; 24(7):543-9. PubMed ID: 11043657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Return of the lysergamides. Part VI: Analytical and behavioural characterization of 1-cyclopropanoyl-d-lysergic acid diethylamide (1CP-LSD).
    Brandt SD; Kavanagh PV; Westphal F; Stratford A; Odland AU; Klein AK; Dowling G; Dempster NM; Wallach J; Passie T; Halberstadt AL
    Drug Test Anal; 2020 Jun; 12(6):812-826. PubMed ID: 32180350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development and application of a gas chromatography-mass spectrometric (GC-MS) assay to determine the presence of 2-oxo-3-hydroxy-LSD in urine.
    Burnley BT; George S
    J Anal Toxicol; 2003; 27(4):249-52. PubMed ID: 12820748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The quantitation of 2-oxo-3-hydroxy lysergic acid diethylamide (O-H-LSD) in human urine specimens, a metabolite of LSD: comparative analysis using liquid chromatography-selected ion monitoring mass spectrometry and liquid chromatography-ion trap mass spectrometry.
    Poch GK; Klette KL; Anderson C
    J Anal Toxicol; 2000 Apr; 24(3):170-9. PubMed ID: 10774536
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a commercial radioimmunoassay kit for the detection of lysergide (LSD) in serum, whole blood, urine and stomach contents.
    Altunkaya D; Smith RN
    Forensic Sci Int; 1990 Sep; 47(2):113-21. PubMed ID: 2227729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.